Epstein Secrets

ing on `unsustainable drug prices' concludes — Hybrid hearing on `Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM * Tom Lantos Human

fter noting "that Mueller had declined his invitation to testify, Graham delivered a general invitation to committee members in the room to request Weissmann as a witness." Graham told Comey, "If you want [Andrew] Weissmann to come, I would invite him." Mueller released a "rare statement on Tuesday to def

g review of the origins of the FBI's investigation into Russian meddling in the 2016 presidential election and the Trump campaign's ties to Russia." Weissmann told CBSN, "I have not been subpoenaed and I don't anticipate it," adding, "I'm happy to give any information I have. I don't think, given what I u

ing on 'unsustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

After noting "that Mueller had declined his invitation to testify, Graham delivered a general invitation to committee members in the room to request Weissmann as a witness." Graham told Comey, "If you want [Andrew] Weissmann to come, I would invite him." Mueller released a "rare statement on Tuesday to de

review of the origins of the FBI's investigation into Russian meddling in the 2016 presidential election and the Trump campaign's ties to Russia." Weissmann told CBSN, "I have not been subpoenaed and I don't anticipate it," adding, "I'm happy to give any information I have. I don't think, given what I u

ring on `unsustainable drug prices' concludes - Hybrid hearing on Unsustainable Drug Prices: Testimony from the CEOs (Part II); with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

After noting "that Mueller had declined his invitation to testify, Graham delivered a general invitation to committee members in the room to request Weissmann as a witness." Graham told Comey, "If you want [Andrew] Weissmann to come, I would invite him." Mueller released a "rare statement on Tuesday to de

review of the origins of the FBI's investigation into Russian meddling in the 2016 presidential election and the Trump campaign's ties to Russia." Weissmann told CBSN, "I have not been subpoenaed and I don't anticipate it," adding, "I'm happy to give any information I have. I don't think, given what I u

ng on 'unsustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

After noting "that Mueller had declined his invitation to testify, Graham delivered a general invitation to committee members in the room to request Weissmann as a witness." Graham told Comey, "If you want [Andrew] Weissmann to come, I would invite him." Mueller released a "rare statement on Tuesday to de

review of the origins of the FBI's investigation into Russian meddling in the 2016 presidential election and the Trump campaign's ties to Russia." Weissmann told CBSN, "I have not been subpoenaed and I don't anticipate it," adding, "I'm happy to give any information I have. I don't think, given what I u